BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 36336256)

  • 1. Primary Preventive Care of Hematopoietic Stem Cell Transplantation Survivors: Time to Educate and Empower Recipients and Providers.
    Fulcher J; Blanchard AP; Bredeson C; van Walraven C
    Transplant Cell Ther; 2023 Feb; 29(2):131.e1-131.e6. PubMed ID: 36336256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertension and diabetes mellitus in adult and pediatric survivors of allogeneic hematopoietic cell transplantation.
    Majhail NS; Challa TR; Mulrooney DA; Baker KS; Burns LJ
    Biol Blood Marrow Transplant; 2009 Sep; 15(9):1100-7. PubMed ID: 19660723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Hematopoietic Cell Transplantation on Cardiovascular Risk Factors and Insulin Sensitivity.
    Ketterl TG; Chow EJ; Koves IH; Goodman P; Leisenring WM; Ballard S; Dengel DR; Moran A; Sinaiko AR; Steinberger J; Baker KS
    Transplant Cell Ther; 2024 Feb; 30(2):243.e1-243.e13. PubMed ID: 37935316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ASBMT Practice Guidelines Committee Survey on Long-Term Follow-Up Clinics for Hematopoietic Cell Transplant Survivors.
    Hashmi SK; Lee SJ; Savani BN; Burns L; Wingard JR; Perales MA; Palmer J; Chow E; Meyer E; Marks D; Mohty M; Inamoto Y; Rodriguez C; Nagler A; Sauter C; Komanduri KV; Pidala J; Hamadani M; Johnston L; Shah N; Shaughnessy P; Hamilton BK; Majhail N; Kharfan-Dabaja MA; Schriber J; DeFilipp Z; Tarlock KG; Fanning S; Curtin P; Rizzo JD; Carpenter PA
    Biol Blood Marrow Transplant; 2018 Jun; 24(6):1119-1124. PubMed ID: 29608957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of late cardiovascular complications in survivors of hematopoietic cell transplantation.
    Armenian SH; Sun CL; Mills G; Teh JB; Francisco L; Durand JB; Wong FL; Forman SJ; Bhatia S
    Biol Blood Marrow Transplant; 2010 Aug; 16(8):1138-44. PubMed ID: 20197101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular risk factors in hematopoietic cell transplantation survivors: role in development of subsequent cardiovascular disease.
    Armenian SH; Sun CL; Vase T; Ness KK; Blum E; Francisco L; Venkataraman K; Samoa R; Wong FL; Forman SJ; Bhatia S
    Blood; 2012 Nov; 120(23):4505-12. PubMed ID: 23034279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic Syndrome and Cardiovascular Disease after Hematopoietic Cell Transplantation: Screening and Preventive Practice Recommendations from the CIBMTR and EBMT.
    DeFilipp Z; Duarte RF; Snowden JA; Majhail NS; Greenfield DM; Miranda JL; Arat M; Baker KS; Burns LJ; Duncan CN; Gilleece M; Hale GA; Hamadani M; Hamilton BK; Hogan WJ; Hsu JW; Inamoto Y; Kamble RT; Lupo-Stanghellini MT; Malone AK; McCarthy P; Mohty M; Norkin M; Paplham P; Ramanathan M; Richart JM; Salooja N; Schouten HC; Schoemans H; Seber A; Steinberg A; Wirk BM; Wood WA; Battiwalla M; Flowers MED; Savani BN; Shaw BE; ;
    Biol Blood Marrow Transplant; 2016 Aug; 22(8):1493-1503. PubMed ID: 27184625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with adherence to preventive care practices among hematopoietic cell transplantation survivors.
    Khera N; Chow EJ; Leisenring WM; Syrjala KL; Baker KS; Flowers ME; Martin PJ; Lee SJ
    Biol Blood Marrow Transplant; 2011 Jul; 17(7):995-1003. PubMed ID: 21145404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current Status and Needs of Long-Term Follow-Up Clinics for Hematopoietic Cell Transplantation Survivors: Results of a Nationwide Survey in Japan.
    Kurosawa S; Mori A; Tsukagoshi M; Onishi Y; Ohwada C; Mori T; Goto H; Asano-Mori Y; Nawa Y; Hino M; Fukuchi T; Mori Y; Yamahana R; Inamoto Y; Fukuda T
    Biol Blood Marrow Transplant; 2020 May; 26(5):949-955. PubMed ID: 31962164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMT.
    DeFilipp Z; Duarte RF; Snowden JA; Majhail NS; Greenfield DM; Miranda JL; Arat M; Baker KS; Burns LJ; Duncan CN; Gilleece M; Hale GA; Hamadani M; Hamilton BK; Hogan WJ; Hsu JW; Inamoto Y; Kamble RT; Lupo-Stanghellini MT; Malone AK; McCarthy P; Mohty M; Norkin M; Paplham P; Ramanathan M; Richart JM; Salooja N; Schouten HC; Schoemans H; Seber A; Steinberg A; Wirk BM; Wood WA; Battiwalla M; Flowers ME; Savani BN; Shaw BE
    Bone Marrow Transplant; 2017 Feb; 52(2):173-182. PubMed ID: 27548466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tailoring a Survivorship Care Plan: Patient and Provider Preferences for Recipients of Hematopoietic Cell Transplantation.
    Denzen EM; Preussler JM; Murphy EA; Baker KS; Burns LJ; Foster J; Idossa L; Moore HK; Payton TJ; Haven D; Jahagirdar B; Kamani N; Rizzo JD; Salazar L; Schatz BA; Syrjala KL; Wingard JR; Majhail NS
    Biol Blood Marrow Transplant; 2019 Mar; 25(3):562-569. PubMed ID: 30315940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation.
    Majhail NS; Rizzo JD; Lee SJ; Aljurf M; Atsuta Y; Bonfim C; Burns LJ; Chaudhri N; Davies S; Okamoto S; Seber A; Socie G; Szer J; Van Lint MT; Wingard JR; Tichelli A; ; ; ; ; ; ;
    Bone Marrow Transplant; 2012 Mar; 47(3):337-41. PubMed ID: 22395764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation.
    Majhail NS; Rizzo JD; Lee SJ; Aljurf M; Atsuta Y; Bonfim C; Burns LJ; Chaudhri N; Davies S; Okamoto S; Seber A; Socie G; Szer J; Van Lint MT; Wingard JR; Tichelli A; ; ; ; ; ; ;
    Biol Blood Marrow Transplant; 2012 Mar; 18(3):348-71. PubMed ID: 22178693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PROMIS measures can be used to assess symptoms and function in long-term hematopoietic cell transplantation survivors.
    Shaw BE; Syrjala KL; Onstad LE; Chow EJ; Flowers ME; Jim H; Baker KS; Buckley S; Fairclough DL; Horowitz MM; Lee SJ
    Cancer; 2018 Feb; 124(4):841-849. PubMed ID: 29072787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematopoietic Stem Cell Transplant Recipients Surviving at Least 2 Years from Transplant Have Survival Rates Approaching Population Levels in the Modern Era of Transplantation.
    Kliman D; Nivison-Smith I; Gottlieb D; Hamad N; Kerridge I; Purtill D; Szer J; Ma D
    Biol Blood Marrow Transplant; 2020 Sep; 26(9):1711-1718. PubMed ID: 32194285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiologic Frailty in Nonelderly Hematopoietic Cell Transplantation Patients: Results From the Bone Marrow Transplant Survivor Study.
    Arora M; Sun CL; Ness KK; Teh JB; Wu J; Francisco L; Armenian SH; Schad A; Namdar G; Bosworth A; Kuo L; Weisdorf DJ; Forman SJ; Bhatia S
    JAMA Oncol; 2016 Oct; 2(10):1277-1286. PubMed ID: 27254472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Patient-Centered Outcomes Working Group Report.
    Bevans M; El-Jawahri A; Tierney DK; Wiener L; Wood WA; Hoodin F; Kent EE; Jacobsen PB; Lee SJ; Hsieh MM; Denzen EM; Syrjala KL
    Biol Blood Marrow Transplant; 2017 Apr; 23(4):538-551. PubMed ID: 27660168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular Function in Long-Term Hematopoietic Cell Transplantation Survivors.
    Armenian SH; Horak D; Scott JM; Mills G; Siyahian A; Berano Teh J; Douglas PS; Forman SJ; Bhatia S; Jones LW
    Biol Blood Marrow Transplant; 2017 Apr; 23(4):700-705. PubMed ID: 28065839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health care utilization by adult long-term survivors of hematopoietic cell transplant: report from the Bone Marrow Transplant Survivor Study.
    Shankar SM; Carter A; Sun CL; Francisco L; Baker KS; Gurney JG; Weisdorf DG; Forman SJ; Robison LL; Grant M; Bhatia S
    Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):834-9. PubMed ID: 17416780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late Effects Surveillance Recommendations among Survivors of Childhood Hematopoietic Cell Transplantation: A Children's Oncology Group Report.
    Chow EJ; Anderson L; Baker KS; Bhatia S; Guilcher GM; Huang JT; Pelletier W; Perkins JL; Rivard LS; Schechter T; Shah AJ; Wilson KD; Wong K; Grewal SS; Armenian SH; Meacham LR; Mulrooney DA; Castellino SM
    Biol Blood Marrow Transplant; 2016 May; 22(5):782-95. PubMed ID: 26802323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.